New insights into the prodromal phase of migraine
Professor Peter Goadsby dissects the prodromal phase of a migraine attack and reveals some of the novel findings behind this common and debilitating neurologic disorder.
Karsan N & Goadsby P. Biological insights from the premonitory symptoms of migraine. Nat Rev Neurol. 2018; 14(12): 699–710, doi: 10.1038/s41582-018-0098-4.
Professor Peter Goadsby has received grants and consultancy/honoraria fees from Amgen and Eli-Lilly and Company, and consultancy/honoraria fees from Alder Biopharmaceuticals, Allergan, Autonomic Technologies Inc., Biohaven Pharmaceuticals Inc., Dr Reddy's Laboratories, Electrocore LLC, eNeura, Impel Neuropharma, MundiPharma, Novartis, Teva Pharmaceuticals, Trigemina Inc. and WL Gore. He has received consultancy/honoraria fees for medico-legal work from Massachusetts Medical Society, Up-to-Date, Oxford University Press, and Wolters Kluwer; and a patent magnetic stimulation for headache assigned to eNeura without fee.